Page last updated: 2024-09-03

2-mercaptomethyl-3-guanidinoethylthiopropionic acid and angiotensin iii

2-mercaptomethyl-3-guanidinoethylthiopropionic acid has been researched along with angiotensin iii in 2 studies

Compound Research Comparison

Studies
(2-mercaptomethyl-3-guanidinoethylthiopropionic acid)
Trials
(2-mercaptomethyl-3-guanidinoethylthiopropionic acid)
Recent Studies (post-2010)
(2-mercaptomethyl-3-guanidinoethylthiopropionic acid)
Studies
(angiotensin iii)
Trials
(angiotensin iii)
Recent Studies (post-2010) (angiotensin iii)
4402628453

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Clark, KL; Cunoosamy, MP; Robertson, MJ1
Batt, CM; Hanesworth, JM; Harding, JW; Jensen, LL; Wright, JW1

Other Studies

2 other study(ies) available for 2-mercaptomethyl-3-guanidinoethylthiopropionic acid and angiotensin iii

ArticleYear
Effects of peptidase inhibition on angiotensin receptor agonist and antagonist potency in rabbit isolated thoracic aorta.
    British journal of pharmacology, 1992, Volume: 106, Issue:1

    Topics: 3-Mercaptopropionic Acid; Adrenergic alpha-Agonists; Amino Acid Sequence; Aminopeptidases; Angiotensin II; Angiotensin III; Animals; Anti-Bacterial Agents; Aorta, Thoracic; Dose-Response Relationship, Drug; In Vitro Techniques; Leucine; Male; Molecular Sequence Data; Muscle Contraction; Oligopeptides; Peptides; Phenylephrine; Rabbits; Receptors, Angiotensin; Vasoconstriction

1992
Intracerebroventricularly applied peptidase inhibitors increase endogenous angiotensin levels.
    Brain research, 1990, Oct-08, Volume: 529, Issue:1-2

    Topics: 3-Mercaptopropionic Acid; Angiotensin II; Angiotensin III; Animals; Anti-Bacterial Agents; Blood Pressure; Carboxypeptidases; Cerebral Ventricles; Injections, Intraventricular; Leucine; Male; Oligopeptides; Peptides; Protease Inhibitors; Radioimmunoassay; Rats; Rats, Inbred Strains

1990